P17.50PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS Article

Kumthekar, P, Grimm, SA, Marymont, M et al. (2014). P17.50PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS . NEURO-ONCOLOGY, 16(suppl_2), ii99-ii99. 10.1093/neuonc/nou174.379

cited authors

  • Kumthekar, P; Grimm, SA; Marymont, M; Mehta, M; Chandler, J; Muro, K; Jovanovic, B; Helenowski, I; McCarthy, K; Raizer, J

authors

publication date

  • September 1, 2014

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • ii99

end page

  • ii99

volume

  • 16

issue

  • suppl_2